Forus, which uses AI to help patients get prescribed drugs more quickly by navigating steps like insurance coverage, raised a $150M Series C at a $3B valuation (Micah Barkley/Bloomberg)

Forus secured a $150 million Series C round, valuing the AI-driven patient-navigation platform at $3 billion as it streamlines insurance and prescription processes. Meanwhile, Mistral raised a €3 billion Series D led by Samsung, lifting its valuation to €21 billion while expanding from AI model development into European data-center services.